Cargando…
Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This stu...
Autores principales: | Fujita, Misuzu, Nagashima, Kengo, Shimazu, Minobu, Suzuki, Misae, Tauchi, Ichiro, Sakuma, Miwa, Yamamoto, Setsuko, Hanaoka, Hideki, Shozu, Makio, Tsuruoka, Nobuhide, Kasai, Tokuzo, Hata, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249862/ https://www.ncbi.nlm.nih.gov/pubmed/37289798 http://dx.doi.org/10.1371/journal.pone.0286909 |
Ejemplares similares
-
Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection
por: Fujita, Misuzu, et al.
Publicado: (2022) -
Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial
por: Fujita, Misuzu, et al.
Publicado: (2022) -
Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan
por: Fujita, Misuzu, et al.
Publicado: (2023) -
Changes in colorectal cancer treatment during the COVID-19 pandemic in Japan: Interrupted time-series analysis using the National Database of Japan
por: Fujita, Misuzu, et al.
Publicado: (2023) -
Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan
por: Fujita, Misuzu, et al.
Publicado: (2023)